Combangio, Inc: Clinical Trials

1 trial sponsored by Combangio, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Combangio, Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
KPI-012, KPI-012 Vehicle - Persistent Corneal Epithelial Defect
Phase 2TerminatedCombangio, Inc1032023-02-072025-10-22

Countries

Argentina (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Kristie Veasey (1)